Unknown

Dataset Information

0

Adipose-Derived Mesenchymal Stem Cells Ameliorate Lipid Metabolic Disturbance in Mice.


ABSTRACT:

Unlabelled

: Adipose-derived mesenchymal stem cells (AD-MSCs) have been shown to ameliorate hyperglycemia in diabetic animals and individuals. However, little is known about whether AD-MSCs affect lipid metabolism. Here we have demonstrated for the first time that AD-MSC infusion can significantly suppress the increase in body weight and remarkably improve dyslipidemia in db/db obese mice and diet-induced obesity mice. Induction of white fat tissue "browning" and activation of adenosine monophosphate-activated protein kinase and its downstream hormone-sensitive lipase in adipose tissue contribute to the antiobesity and lipid-lowering effects. Thus, AD-MSC infusion holds great therapeutic potential for dyslipidemia and associated cardiovascular diseases.

Significance

Mesenchymal stem cells (MSCs) are considered one of the most promising types of stem cells for translational application because of their rich tissue sources, multilineage differentiation capacity, and easy amplification in vitro and unique immunobiological properties. This study demonstrated that adipose-derived MSCs (AD-MSCs) infusion can significantly suppress the increase in body weight and remarkably improve dyslipidemia in obese mice. Induction of white fat tissue "browning" and activation of adenosine monophosphate-activated protein kinase and its downstream hormone-sensitive lipase in adipose tissue were demonstrated to contribute to the antiobesity and lipid-lowering effects. Thus, AD-MSC infusion holds great therapeutic potential for dyslipidemia.

SUBMITTER: Liu GY 

PROVIDER: S-EPMC4996437 | biostudies-literature | 2016 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Adipose-Derived Mesenchymal Stem Cells Ameliorate Lipid Metabolic Disturbance in Mice.

Liu Guang-Yang GY   Liu Jin J   Wang You-Liang YL   Liu Yang Y   Shao Yong Y   Han Yan Y   Qin Ya-Ru YR   Xiao Feng-Jun FJ   Li Peng-Fei PF   Zhao Lan-Jun LJ   Gu En-Yan EY   Chen Si-Yu SY   Gao Li-Hua LH   Wu Chu-Tse CT   Hu Xian-Wen XW   Duan Hai-Feng HF  

Stem cells translational medicine 20160705 9


<h4>Unlabelled</h4>: Adipose-derived mesenchymal stem cells (AD-MSCs) have been shown to ameliorate hyperglycemia in diabetic animals and individuals. However, little is known about whether AD-MSCs affect lipid metabolism. Here we have demonstrated for the first time that AD-MSC infusion can significantly suppress the increase in body weight and remarkably improve dyslipidemia in db/db obese mice and diet-induced obesity mice. Induction of white fat tissue "browning" and activation of adenosine  ...[more]

Similar Datasets

| S-EPMC5763137 | biostudies-literature
| S-EPMC9587124 | biostudies-literature
| S-EPMC3844199 | biostudies-literature
| S-EPMC4342568 | biostudies-other
| S-EPMC6496133 | biostudies-literature
| S-EPMC5614481 | biostudies-literature
| S-EPMC4714505 | biostudies-literature
| S-EPMC4740412 | biostudies-literature
| S-EPMC3110196 | biostudies-literature
| S-EPMC6854183 | biostudies-literature